Olympus Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Robert White
- Full Time Employees
- 28,138
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 2951, Ishikawa-machi Tokyo TY Japan 192-8507
- IPO Date
- May 16, 1949
- Website
- olympus.co.jp
- Similar Companies
- Business
- Olympus Corporation (7733.T), a leading global medical technology company founded in 1919 and headquartered in Tokyo, Japan, develops, manufactures and markets precision instruments primarily focused on endoscopy-enabled care, operating through Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others segments; its core products encompass gastrointestinal and surgical endoscopes, endotherapy devices including energy devices and guidewires, urology and gynecology products such as cystoscopes and single-use devices, respiratory-endotherapy bronchoscopes, ear-nose-throat solutions, surgical microscopes like ORBEYE, imaging platforms including VISERA 4K UHD and EasySuite 4K systems, biological and industrial microscopes, non-destructive testing equipment, X-ray fluorescence analyzers, and biomedical materials including orthopedic equipment, serving healthcare providers, researchers and industrial customers across Japan, North America, Europe, Asia, the Middle East and Oceania. The company maintains a dominant position in minimally invasive diagnosis and treatment technologies, with recent advancements including the U.S. launch of the OLYSENSE platform featuring CADe/AI solutions, distribution partnerships with W.L. Gore & Associates for EndoTherapy expansion and MacroLux Medical for single-use urology products, CE approval for three cloud-based AI medical devices with a planned 2025 AI-powered endoscopy ecosystem rollout, acquisition of a distribution business in Chile to strengthen Latin American presence, and a comprehensive corporate strategy unveiled in November 2025 emphasizing innovation-driven growth in AI, robotics and digital ecosystems alongside organizational simplification targeting 24 billion yen in run-rate savings and a net workforce reduction of approximately 2,000 positions by fiscal 2027, complemented by leadership transitions such as Keith Boettiger's appointment as Gastrointestinal Solutions Division Head effective April 2026.
Company News
Olympus Co. (OTCMKTS:OLYMY) Short Interest Update
Olympus Corporation (OLYMY) Q3 2026 Earnings Call Transcript
Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Olympus (OTCMKTS:OCPNY) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
Olympus Corporation (OLYMY) Discusses New Strategic Vision and Expansion of Endoscopy-Enabled Care Prepared Remarks Transcript
Olympus Corporation (OLYMY) Q1 2026 Earnings Call Transcript
Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf
Apollo Announces Olympus Housing Capital
Olympus Corporation (OLYMY) Q4 2025 Earnings Call Transcript
Olympian Motors and Foxconn Partner to Launch Olympus OS: AI-Defined Vehicle Operating System
Monroe Capital Supports Olympus Partners' Acquisition of PAI Pharma
Monroe Capital Supports Olympus Partners' Acquisition of Accelevation Holding Company, LLC
Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript
Olympus Corporation (OLYMY) Q2 2025 Earnings Call Transcript
Olympus Corporation (OLYMY) Q1 2025 Earnings Call Transcript
Olympus Corporation (OLYMY) Q4 2024 Earnings Call Transcript
Olympus Corporation (OLYMY) Q3 2024 Earnings Call Transcript
Olympus Corporation (OCPNF) Q2 2024 Earnings Call Transcript